Entity Common Stock, Shares Outstanding of BetterLife Pharma Inc. from 31 Jul 2011 to 30 May 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BetterLife Pharma Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2011 to 30 May 2025.
  • BetterLife Pharma Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 May 2025 was 145,494,883.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BetterLife Pharma Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 145,494,883 30 May 2025 20-F 02 Jun 2025 2025 FY
Q4 2023 117,079,397 +8,404,092 +7.7% 31 Jan 2024 20-F 30 May 2024 2024 FY
Q4 2022 108,675,305 +23,434,067 +27% 31 Jan 2023 20-F/A 06 Jun 2023 2023 FY
Q4 2021 85,241,238 +33,795,396 +66% 31 Jan 2022 20-F 06 Jun 2022 2022 FY
Q4 2020 51,445,842 -120,635,293 -70% 31 Jan 2021 20-F/A 23 Jun 2021 2021 FY
Q4 2019 172,081,135 +75,502,886 +78% 31 Jan 2020 20-F/A 05 Jun 2020 2020 FY
Q2 2019 171,039,468 +82,600,721 +93% 17 Jun 2019 10-Q 17 Jun 2019 2020 Q1
Q1 2019 106,244,230 +18,189,070 +21% 02 May 2019 10-K 03 May 2019 2019 FY
Q4 2018 96,578,249 +14,354,926 +17% 18 Dec 2018 10-Q 18 Dec 2018 2019 Q3
Q3 2018 88,679,077 +12,831,963 +17% 14 Sep 2018 10-Q 14 Sep 2018 2019 Q2
Q2 2018 88,438,747 +12,791,633 +17% 19 Jun 2018 10-Q 19 Jun 2018 2018 Q1
Q1 2018 88,055,160 +12,408,046 +16% 01 May 2018 10-K 01 May 2018 2018 FY
Q4 2017 82,223,323 +6,576,223 +8.7% 15 Dec 2017 10-Q 15 Dec 2017 2018 Q3
Q3 2017 75,847,114 +225,014 +0.3% 15 Sep 2017 10-Q 15 Sep 2017 2018 Q2
Q2 2017 75,647,114 +675,000 +0.9% 13 Jun 2017 10-Q 13 Jun 2017 2018 Q1
Q1 2017 75,647,114 +725,000 +0.97% 28 Apr 2017 10-K 28 Apr 2017 2017 FY
Q4 2016 75,647,100 +924,986 +1.2% 09 Dec 2016 10-Q 12 Dec 2016 2017 Q3
Q3 2016 75,622,100 -34,141,681 -31% 12 Sep 2016 10-Q 12 Sep 2016 2017 Q2
Q2 2016 74,972,114 -3,791,653 -4.8% 14 Jun 2016 10-Q 14 Jun 2016 2017 Q1
Q1 2016 74,922,114 -3,841,653 -4.9% 29 Apr 2016 10-K/A 07 Jun 2016 2016 FY
Q4 2015 74,722,114 -41,044,959 -35% 15 Dec 2015 10-Q 15 Dec 2015 2016 Q3
Q3 2015 109,763,781 10 Sep 2015 10-Q 10 Sep 2015 2016 Q2
Q2 2015 78,763,767 -37,003,306 -32% 17 Jun 2015 10-Q 17 Jun 2015 2016 Q1
Q1 2015 78,763,767 -37,003,306 -32% 15 May 2015 10-K 17 Jun 2015 2015 FY
Q4 2014 115,767,073 +15,000,000 +15% 09 Dec 2014 10-Q 15 Dec 2014 2015 Q3
Q2 2014 115,767,073 +80,000,000 +224% 31 Jul 2014 10-Q 15 Sep 2014 2015 Q2
Q1 2014 115,767,073 +80,000,000 +224% 30 Apr 2014 10-Q 16 Jun 2014 2015 Q1
Q4 2013 100,767,073 +65,000,000 +182% 31 Jan 2014 10-K 16 May 2014 2013 FY
Q3 2013 70,767,073 +35,000,000 +98% 31 Oct 2013 10-Q 16 Dec 2013 2013 Q3
Q2 2013 35,767,073 0 0% 31 Jul 2013 10-Q 16 Sep 2013 2013 Q2
Q1 2013 35,767,073 0 0% 30 Apr 2013 10-Q 19 Jun 2013 2013 Q1
Q4 2012 35,767,073 0 0% 31 Jan 2013 10-K 16 May 2013 2012 FY
Q3 2012 35,767,073 0 0% 31 Oct 2012 10-Q 14 Dec 2012 2012 Q3
Q2 2012 35,767,073 +1,600,000 +4.7% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q2
Q1 2012 35,767,073 30 Apr 2012 10-Q 14 Jun 2012 2012 Q1
Q4 2011 35,767,073 31 Jan 2012 10-K/A 15 May 2012 2011 FY
Q3 2011 35,767,073 31 Oct 2011 10-Q 15 Dec 2011 2011 Q3
Q2 2011 34,167,073 31 Jul 2011 10-Q/A 21 Dec 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.